May 29, 2025

How do hemostatic particles work?

Leave a message

Hemostatic particles have emerged as a revolutionary solution in the field of hemostasis, offering a rapid and effective way to control bleeding. As a leading supplier of hemostatic particles, I am excited to share with you how these remarkable particles work and the benefits they bring to the medical community.

Understanding the Basics of Hemostasis

Before delving into the mechanism of hemostatic particles, it is essential to understand the natural process of hemostasis. Hemostasis is the body's physiological response to stop bleeding, which involves a complex cascade of events. When a blood vessel is damaged, the first step is vasoconstriction, where the blood vessel walls narrow to reduce blood flow. This is followed by the formation of a platelet plug, as platelets adhere to the damaged vessel wall and aggregate together. Finally, the coagulation cascade is activated, leading to the formation of a fibrin clot that stabilizes the platelet plug and seals the wound.

How Hemostatic Particles Intervene in the Hemostatic Process

Hemostatic particles work by accelerating and enhancing the natural hemostatic process. These particles are typically made of biocompatible and biodegradable materials, such as polysaccharides or synthetic polymers. When applied to a bleeding wound, the hemostatic particles quickly absorb water from the blood, creating a concentrated gel-like matrix at the site of injury.

Platelet Activation and Aggregation

The gel-like matrix formed by the hemostatic particles provides a physical scaffold for platelets to adhere to and aggregate. The particles also contain bioactive components that can activate platelets, triggering their release of clotting factors and promoting the formation of a platelet plug. This rapid platelet aggregation helps to seal the damaged blood vessels and reduce blood loss.

Coagulation Cascade Activation

In addition to promoting platelet aggregation, hemostatic particles can also activate the coagulation cascade. The particles can interact with coagulation factors in the blood, accelerating the conversion of prothrombin to thrombin. Thrombin then catalyzes the conversion of fibrinogen to fibrin, which forms a mesh-like network that reinforces the platelet plug and stabilizes the clot.

Mechanical Barrier and Sealing Effect

The gel-like matrix formed by the hemostatic particles acts as a mechanical barrier, preventing further blood loss by physically blocking the flow of blood from the damaged vessel. This sealing effect is particularly important in cases of severe bleeding or in areas where traditional hemostatic methods may be less effective.

Advantages of Hemostatic Particles

The use of hemostatic particles offers several advantages over traditional hemostatic methods, such as sutures, staples, or topical hemostatic agents.

Rapid Hemostasis

One of the primary advantages of hemostatic particles is their ability to achieve rapid hemostasis. The particles can quickly form a clot at the site of injury, reducing blood loss and minimizing the risk of complications associated with excessive bleeding.

Minimally Invasive

Hemostatic particles can be applied topically to the bleeding site, making them a minimally invasive option for controlling bleeding. This is particularly beneficial in cases where surgical intervention may be difficult or contraindicated.

Biocompatibility and Absorbability

Most hemostatic particles are made of biocompatible and biodegradable materials, which are well-tolerated by the body and do not require removal after use. The particles are gradually absorbed by the body over time, eliminating the need for additional procedures and reducing the risk of infection.

Versatility

Hemostatic particles can be used in a variety of clinical settings, including surgical procedures, trauma care, and dental surgery. They can be applied to different types of wounds, such as incisions, lacerations, and puncture wounds, making them a versatile option for hemostasis.

Our Hemostatic Particle Products

As a supplier of hemostatic particles, we offer a range of high-quality products that are designed to meet the diverse needs of our customers. Our Hemostatic Powder is a fine, white powder that can be easily applied to bleeding wounds. It is formulated with a unique blend of polysaccharides and bioactive components, which work together to achieve rapid hemostasis.

0402

Our Absorbable Hemostatic Powder is another popular product in our portfolio. This powder is made of a biodegradable polymer that is rapidly absorbed by the body, leaving no residue behind. It is suitable for use in a variety of surgical procedures, including cardiovascular surgery, orthopedic surgery, and neurosurgery.

In addition to our powder products, we also offer Absorbable Hemostatic Agents in other forms, such as gels and sponges. These products are designed to provide a convenient and effective way to control bleeding in different clinical settings.

Conclusion

Hemostatic particles are a powerful tool in the field of hemostasis, offering a rapid, effective, and minimally invasive way to control bleeding. By accelerating the natural hemostatic process and providing a mechanical barrier, these particles can help to reduce blood loss, minimize the risk of complications, and improve patient outcomes.

If you are interested in learning more about our hemostatic particle products or would like to discuss your specific hemostasis needs, please do not hesitate to contact us. Our team of experts is available to provide you with detailed information and support to help you make the right choice for your patients.

References

  1. Lee, A. W., & Wong, T. T. (2019). Hemostatic agents: A review of current and emerging products. Journal of Clinical and Experimental Dentistry, 11(4), e422-e428.
  2. Maitz, P. K., & van der Ven, C. J. (2018). Hemostatic agents in trauma: A systematic review. Journal of Trauma and Acute Care Surgery, 85(6), 1177-1184.
  3. Shaffer, M. S., & Holcomb, J. B. (2017). Hemostatic agents for the control of bleeding in trauma. Current Opinion in Critical Care, 23(6), 543-549.
Send Inquiry